tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market
XERS
Xeris Pharmaceuticals
RESEARCH TOOLSreports
Want to see XERS full AI Analyst Report?

Xeris Pharmaceuticals (XERS) Income Statement

1,099 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q4 2025), Xeris Pharmaceuticals's total revenue was $85.81M, an increase of 42.78% from the same quarter last year. In Q4, Xeris Pharmaceuticals's net income was $11.08M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 291.85M$ 203.07M$ 163.91M$ 110.25M$ 49.59M
Gross Profit
$ 238.43M$ 166.24M$ 135.27M$ 87.61M$ 36.27M
Operating Expenses
$ 213.54M$ 199.88M$ 179.28M$ 169.55M$ 151.43M
Depreciation and Amortization
$ 12.16M$ 12.63M$ 13.16M$ 12.67M$ 1.88M
EBITDA
$ 12.71M$ -13.99M$ -23.73M$ -69.31M$ -113.67M
Operating Income
$ 24.90M$ -33.65M$ -44.01M$ -81.94M$ -115.16M
Other Income/Expenses
$ -24.34M$ -23.46M$ -19.49M$ -14.14M$ -7.57M
Pretax Income
$ 554.00K$ -57.10M$ -63.50M$ -96.08M$ -122.72M
Net Income
$ 554.00K$ -54.84M$ -62.26M$ -94.66M$ -122.72M
Per Share Metrics
Basic EPS
$ <0.01$ -0.37$ -0.45$ -0.70$ -1.55
Diluted EPS
$ <0.01$ -0.37$ -0.45$ -0.70$ -1.55
Weighted Average Shares Outstanding
 160.43M 146.77M 137.67M 135.63M 79.03M
Weighted Average Shares Outstanding (Diluted)
 172.74M 146.77M 137.67M 135.63M 79.03M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History